Keywords: Canada, Generics industry, Patent expiry, RNCOS, Aging population

Growth of generics industry remains upbeat in Canada

Article | 14 January 2011

The generic drugs industry in Canada is anticipated to expand at a compound annual growth rate (CAGR) of around 14% during 2009 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in